Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04464785 · ClinicalTrials.gov registry record
CentriMag Failure-to-Wean Post Approval Study
A clinical trial, sponsored by Abbott Medical Devices.
- Completed
- Registry status
- 32
- Enrollment target
NCT04464785 is a clinical trial that has completed, run by Abbott Medical Devices. The registered enrollment target is 32 participants.
The verdict
NCT04464785 has completed, sponsored by Abbott Medical Devices.
- COMPLETED
- Registry status
- 32 participants
- Enrollment target
Study Summary
The primary objective of this Post Approval Study is to report the proportion of patients surviving to 30 days post CentriMag support or to hospital discharge, whichever is longer. For subjects who do not recover and are bridged to a heart transplant or a long-term assist device, the primary endpoint is survival to induction of anesthesia for the surgery.
Interventions
- DEVICE CentriMag Circulatory Support System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 32 participants |
| Start Date | 2020-12-30 |
| Est. Completion | 2024-10-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04464785
The ClinicalTrials.gov registry entry for NCT04464785 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 32 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Abbott Medical Devices, which has 261 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which CentriMag Circulatory Support System is the first listed.
NCT04464785 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04464785 about?
NCT04464785 is a clinical study titled "CentriMag Failure-to-Wean Post Approval Study". The primary objective of this Post Approval Study is to report the proportion of patients surviving to 30 days post CentriMag support or to hospital discharge, whichever is longer. For subjects who do not recover and are bridged to a heart transplant or a long-term assist device, the primary endpoin...
What is the current status of trial NCT04464785?
This trial is currently completed. The enrollment target is 32 participants. The study started on 2020-12-30. Estimated completion is 2024-10-25.
What interventions are being tested in trial NCT04464785?
The interventions under investigation include: CentriMag Circulatory Support System (DEVICE).
Who is sponsoring clinical trial NCT04464785?
This trial is sponsored by Abbott Medical Devices, which has 261 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.